Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.330
-0.005 (-0.37%)
At close: Jan 6, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of $125.74 million as of January 8, 2026. Its market cap has increased by 150.64% in one year.
Market Cap
125.74M
Enterprise Value
145.43M
Revenue
78.03M
Ranking
n/a
PE Ratio
13.21
Stock Price
$1.33
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 125.74M, a decrease of -21.13%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 125.74M | 4.31% |
| Dec 31, 2025 | 120.54M | 160.36% |
| Dec 31, 2024 | 46.30M | -18.17% |
| Dec 29, 2023 | 56.58M | -8.15% |
| Dec 30, 2022 | 61.59M | -34.13% |
| Dec 31, 2021 | 93.50M | 101.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |